S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
NASDAQ:PALI

Palisade Bio (PALI) Stock Price, News & Analysis

$0.36
0.00 (0.00%)
(As of 03/18/2024 ET)
Today's Range
$0.36
$0.37
50-Day Range
$0.36
$0.96
52-Week Range
$0.36
$3.65
Volume
77,873 shs
Average Volume
3.08 million shs
Market Capitalization
$3.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.75

Palisade Bio MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
2,312.5% Upside
$8.75 Price Target
Short Interest
Healthy
0.85% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$6,000 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.92) to ($0.82) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.13 out of 5 stars

PALI stock logo

About Palisade Bio Stock (NASDAQ:PALI)

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor tranexamic acid to reduce the formation of postoperative adhesions, postoperative ileus, and return of bowel function in adults. It has a license agreement with the Regents of the University of California; and co-development and distribution agreement with Newsoara Biopharma Co., Ltd. Palisade Bio, Inc. is based in Carlsbad, California.

PALI Stock Price History

PALI Stock News Headlines

AI Cracks Open Largest Untapped Energy Reserve on Earth
This orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… 
AI Cracks Open Largest Untapped Energy Reserve on Earth
This orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… 
Palisade Bio Shares Drop 23% After Warrants Exercised
Why Is Palisade Bio (PALI) Stock Up 100% Today?
Stocks to Watch: Palisade Bio
Palisade Bio files to sell its shares
Palisade Bio Inc PALI
See More Headlines
Receive PALI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Palisade Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
3/18/2024
Next Earnings (Estimated)
3/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PALI
Fax
N/A
Employees
12
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.75
High Stock Price Target
$16.00
Low Stock Price Target
$1.50
Potential Upside/Downside
+2,277.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-14,260,000.00
Pretax Margin
-5,219.60%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.24 per share

Miscellaneous

Free Float
9,063,000
Market Cap
$3.41 million
Optionable
Not Optionable
Beta
1.33
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

PALI Stock Analysis - Frequently Asked Questions

Should I buy or sell Palisade Bio stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Palisade Bio in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" PALI shares.
View PALI analyst ratings
or view top-rated stocks.

What is Palisade Bio's stock price target for 2024?

1 brokerages have issued 12 month price targets for Palisade Bio's shares. Their PALI share price targets range from $1.50 to $16.00. On average, they anticipate the company's stock price to reach $8.75 in the next twelve months. This suggests a possible upside of 2,312.5% from the stock's current price.
View analysts price targets for PALI
or view top-rated stocks among Wall Street analysts.

How have PALI shares performed in 2024?

Palisade Bio's stock was trading at $0.59 at the beginning of the year. Since then, PALI stock has decreased by 38.5% and is now trading at $0.3627.
View the best growth stocks for 2024 here
.

Are investors shorting Palisade Bio?

Palisade Bio saw a decrease in short interest in the month of February. As of February 29th, there was short interest totaling 76,800 shares, a decrease of 23.9% from the February 14th total of 100,900 shares. Based on an average daily volume of 2,610,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.9% of the shares of the company are sold short.
View Palisade Bio's Short Interest
.

When is Palisade Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 27th 2024.
View our PALI earnings forecast
.

How were Palisade Bio's earnings last quarter?

Palisade Bio, Inc. (NASDAQ:PALI) released its earnings results on Thursday, November, 9th. The company reported ($0.49) EPS for the quarter, missing analysts' consensus estimates of ($0.40) by $0.09.

Who are Palisade Bio's major shareholders?

Palisade Bio's stock is owned by a number of institutional and retail investors. Top institutional investors include Virtu Financial LLC (0.56%). Insiders that own company stock include Donald Allen Williams, John David Finley, Michael John Dawson, Robert J Trenschel, Robert J Trenschel and Thomas Hallam.
View institutional ownership trends
.

How do I buy shares of Palisade Bio?

Shares of PALI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PALI) was last updated on 3/19/2024 by MarketBeat.com Staff

From Our Partners